PAS
IDYA icon

Park Avenue Securities’s IDEAYA Biosciences IDYA Stock Holding History

Park Avenue Securities’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$224K Sell
6,722
-1,492
-18% -$50.1K ﹤0.01% 1431
2025
Q4 		$284K Sell
8,214
-94
-1% -$3K ﹤0.01% 1336
2025
Q3 		$226K Buy
+8,308
New +$201K ﹤0.01% 1522

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Park Avenue Securities's IDYA Position: Q1 2026 in Review

Park Avenue Securities reduced its IDEAYA Biosciences (IDYA) stake by 18% in Q1 2026, selling an estimated $50.1K and leaving 6,722 shares worth $224K. The position accounts for ﹤0.01% of the portfolio, ranked #1431.

Park Avenue Securities first reported a position in IDYA in Q3 2025 and has held it in 3 quarters since. The position peaked at $284K in Q4 2025. 253 funds tracked by Wall St. Rank hold IDYA as of Q1 2026.

  • Park Avenue Securities held 6,722 shares of IDEAYA Biosciences worth $224K as of Q1 2026.
  • Park Avenue Securities sold 1,492 IDEAYA Biosciences shares in Q1 2026, an estimated $50.1K.
  • IDEAYA Biosciences made up ﹤0.01% of Park Avenue Securities's portfolio in Q1 2026, its #1431 holding.
  • Park Avenue Securities first reported a position in IDEAYA Biosciences in Q3 2025 and has held it in 3 quarters since.
  • Park Avenue Securities's IDEAYA Biosciences position peaked at $284K in Q4 2025.
  • 253 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q1 2026.

Based on Park Avenue Securities's 13F filing for Q1 2026, filed 7 Apr 2026.